マイクロ流体デバイスを用いたCD9結合ペプチド搭載脂質ナノ粒子の開発

抄録

Lipid nanoparticles (LNPs) are promising drug delivery carriers due to their high biocompatibility and targeting ability. In this study, we developed LNPs encapsulating a CD9-binding peptide (CD9-BP), which inhibits cancer